Suchergebnisse - "Ardoino, I"

PubPharm (19)

11

Abstract P2-06-07: Risk of metastases after ipsilateral breast tumour recurrence changes overtime according to patient and tumour characteristics: Implications for treatment

enthalten in: Cancer research | 2017

von Gennaro, M. | Di Cosimo, S. | Ardoino, I. | +6

12

Pattern of in‐hospital changes in drug use in the older people from 2010 to 2016

enthalten in: Pharmacoepidemiology and drug safety | 2017

von Franchi, C. | Ardoino, I. | Nobili, A. | +4

13

Risk factors and epidemiology of Acinetobacter baumannii infections in a university hospital in Northern Italy : A case-control study

enthalten in: American journal of infection control | 2016

von Ardoino, I. | Zangirolami, F. | Iemmi, D. | +4

14

Prevalence and Risk Factors Associated with Use of QT-Prolonging Drugs in Hospitalized Older People

enthalten in: Drugs & aging | 2016

von Franchi, C. | Ardoino, I. | Rossio, R. | +109

15

Risk factors and epidemiology of Acinetobacter baumannii infections in a university hospital in Northern Italy: A case-control study

enthalten in: American journal of infection control | 2016

von Ardoino, I. | Zangirolami, F. | Iemmi, D. | +4

16

Risk factors and epidemiology of Acinetobacter baumannii infections in a university hospital in Northern Italy: A case-control study

enthalten in: American journal of infection control | 2016

von Ardoino, I. | Zangirolami, F. | Iemmi, D. | +4

17

Prevalence and Risk Factors Associated with Use of QT-Prolonging Drugs in Hospitalized Older People

enthalten in: Drugs & aging | 2016

von Franchi, C. | Ardoino, I. | Rossio, R. | +8

18

Prevalence and Risk Factors Associated with Use of QT-Prolonging Drugs in Hospitalized Older People

enthalten in: Drugs & aging | 2015

von Franchi, C. | Ardoino, I. | Rossio, R. | +8

19

Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients

enthalten in: Reumatismo | 2014

von Romano, M. | Pontikaki, I. | Gattinara, M. | +5